Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Priya Khurana"'
Autor:
Branden Moriarity, Marilyn Marques, Vipin Suri, Bashar Hamza, Angela Nunez, Henry Moreno, Alexia Barandiaran, Evelyn Warren, Cristina Panaroni, Michele McAuliffe, Krista Daniel, Julianne Murthy, Keith HK Wong, Mark Omobono, Priya Khurana, Beatriz Marques, Adriana Rivera, Jae Woong Chang, Joseph Gold, Cherry Thomas, Dominic Picarella
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f735c5dd6f6149f5b0827c3e10c3efe5
Autor:
Dongdong Chen, Julie Cox, Jayabhargav Annam, Melanie Weingart, Grace Essien, Komal S. Rathi, Jo Lynne Rokita, Priya Khurana, Selma M. Cuya, Kristopher R. Bosse, Adeiye Pilgrim, Daisy Li, Cara Shields, Oskar Laur, John M. Maris, Robert W. Schnepp
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 6, Pp 231-241 (2020)
Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the
Externí odkaz:
https://doaj.org/article/ad151ae47c9f49dea91c5b91b570dcb8
Autor:
Priya Khurana, Chakkapong Burudpakdee, Stephan A. Grupp, Ulf H. Beier, David M. Barrett, Hamid Bassiri
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Invariant natural killer T (iNKT) cells comprise a unique subset of lymphocytes that are primed for activation and possess innate NK-like functional features. Currently, iNKT cell-based immunotherapies remain in early clinical stages, and little is k
Externí odkaz:
https://doaj.org/article/cba694a0cd1e44b5a960cff9055f4538
Publikováno v:
Journal of Clinical and Translational Science, Vol 3, Pp 21-21 (2019)
OBJECTIVES/SPECIFIC AIMS: Overall Research Aim: To develop an iNKT-cell engaging reagent (“CAb”)to induce neuroblastoma-directed cytotoxicity in vitro and in a mouse model of neuroblastoma. Objective 1: Explore the contribution of different GD2 a
Externí odkaz:
https://doaj.org/article/07feaba85f4043da99b65a817d666ab3
Autor:
Priya , Khurana
Publikováno v:
International Journal of Inclusive Development. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04657224a8b4c350841f61dc60c2766a
https://doi.org/10.30954/2454-4132.2.2022.11
https://doi.org/10.30954/2454-4132.2.2022.11
Autor:
Melanie Weingart, Robert W. Schnepp, Komal S. Rathi, John M. Maris, Dongdong Chen, Julie Cox, Cara E. Shields, Kristopher R. Bosse, Priya Khurana, Adeiye Pilgrim, Jo Lynne Rokita, Oskar Laur, Jayabhargav Annam, Grace Essien, Daisy Li, Selma M. Cuya
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 6, Pp 231-241 (2020)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4309a39836c5206ace6754e084152a50
https://doi.org/10.1016/j.neo.2020.04.001
https://doi.org/10.1016/j.neo.2020.04.001
Autor:
Spyridon A. Karageorgos, Hogarty, Hamid Bassiri, Kevin O McNerney, Ferry G, Vemu R, Chakkapong Burudpakdee, Adam J. Wolpaw, Priya Khurana, Annette Vu
BackgroundNeuroblastoma is a commonly lethal solid tumor of childhood and intensive chemoradiotherapy treatment cures ~50% of children with high-risk disease. The addition of immunotherapy using dinutuximab, a monoclonal antibody directed against the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a049180138b845312c34a4ab632bd2e6
https://doi.org/10.1101/2021.06.09.447746
https://doi.org/10.1101/2021.06.09.447746
Autor:
Chakkapong Burudpakdee, Ulf H. Beier, David M. Barrett, Stephan A. Grupp, Hamid Bassiri, Priya Khurana
Invariant natural killer T (iNKT) cells comprise a unique subset of lymphocytes that are primed for activation and possess innate NK-like functional features. Currently, iNKT cell-based immunotherapies remain in early clinical stages, and little is k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5078229c024346b5b9c354c9f4fa95fa
https://doi.org/10.1101/2021.04.29.442021
https://doi.org/10.1101/2021.04.29.442021
Autor:
Grace Essien, Jo Lynne Rokita, Kristopher R. Bosse, Dongdong Chen, Melanie Weingart, Julie Cox, Robert W. Schnepp, Daisy Li, Priya Khurana, Komal S. Rathi, Selma M. Cuya, Jayabhargav Annam, Adeiye Pilgrim, John M. Maris
Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::861b18a8d562c6495901d95c25faaf8a
Autor:
Kristopher R. Bosse, Jo Lynne Harenza, Jayabhargav Annam, Adeiye Pilgrim, Melanie Weingart, Robert W. Schnepp, Selma M. Cuya, Dongdong Chen, Priya Khurana, Komal S. Rathi, John M. Maris, Grace Essien, Julie Cox
Publikováno v:
Cancer Research. 80:B48-B48
Background: Neuroblastoma, an aggressive cancer of the developing sympathetic nervous system, continues to cause significant morbidity and mortality, highlighting the need to identify novel therapeutic vulnerabilities. We previously demonstrated that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4200fcf25409ef69a40cc943d60eed7b
https://doi.org/10.1158/1538-7445.pedca19-b48
https://doi.org/10.1158/1538-7445.pedca19-b48